BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10882342)

  • 1. Lecithin-cholesterol acyltransferase: role in lipoprotein metabolism, reverse cholesterol transport and atherosclerosis.
    Santamarina-Fojo S; Lambert G; Hoeg JM; Brewer HB
    Curr Opin Lipidol; 2000 Jun; 11(3):267-75. PubMed ID: 10882342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis.
    Hoeg JM; Santamarina-Fojo S; Bérard AM; Cornhill JF; Herderick EE; Feldman SH; Haudenschild CC; Vaisman BL; Hoyt RF; Demosky SJ; Kauffman RD; Hazel CM; Marcovina SM; Brewer HB
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11448-53. PubMed ID: 8876155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice.
    Lambert G; Sakai N; Vaisman BL; Neufeld EB; Marteyn B; Chan CC; Paigen B; Lupia E; Thomas A; Striker LJ; Blanchette-Mackie J; Csako G; Brady JN; Costello R; Striker GE; Remaley AT; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 2001 May; 276(18):15090-8. PubMed ID: 11278414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific expression of the human gene for lecithin: cholesterol acyltransferase in transgenic mice alters blood lipids, lipoproteins and lipases towards a less atherogenic profile.
    Mehlum A; Staels B; Duverger N; Tailleux A; Castro G; Fievet C; Luc G; Fruchart JC; Olivecrona G; Skretting G
    Eur J Biochem; 1995 Jun; 230(2):567-75. PubMed ID: 7607230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase.
    Bérard AM; Föger B; Remaley A; Shamburek R; Vaisman BL; Talley G; Paigen B; Hoyt RF; Marcovina S; Brewer HB; Santamarina-Fojo S
    Nat Med; 1997 Jul; 3(7):744-9. PubMed ID: 9212100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in understanding of the role of lecithin cholesterol acyltransferase (LCAT) in cholesterol transport.
    Dobiásová M; Frohlich JJ
    Clin Chim Acta; 1999 Aug; 286(1-2):257-71. PubMed ID: 10511297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis?
    Kunnen S; Van Eck M
    J Lipid Res; 2012 Sep; 53(9):1783-99. PubMed ID: 22566575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LCAT modulates atherogenic plasma lipoproteins and the extent of atherosclerosis only in the presence of normal LDL receptors in transgenic rabbits.
    Brousseau ME; Kauffman RD; Herderick EE; Demosky SJ; Evans W; Marcovina S; Santamarina-Fojo S; Brewer HB; Hoeg JM
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):450-8. PubMed ID: 10669643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lecithin:cholesterol acyltransferase, high-density lipoproteins, and atheroprotection in humans.
    Calabresi L; Franceschini G
    Trends Cardiovasc Med; 2010 Feb; 20(2):50-3. PubMed ID: 20656215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice overexpressing human lecithin: cholesterol acyltransferase are not protected against diet-induced atherosclerosis.
    Mehlum A; Muri M; Hagve TA; Solberg LA; Prydz H
    APMIS; 1997 Nov; 105(11):861-8. PubMed ID: 9393557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
    Furbee JW; Sawyer JK; Parks JS
    J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models.
    Ng DS
    Biochim Biophys Acta; 2012 Apr; 1821(4):654-9. PubMed ID: 22326749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential.
    Lee RG; Kelley KL; Sawyer JK; Farese RV; Parks JS; Rudel LL
    Circ Res; 2004 Nov; 95(10):998-1004. PubMed ID: 15486318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Arg123-Tyr166 central domain of human ApoAI is critical for lecithin:cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice.
    Holvoet P; De Geest B; Van Linthout S; Lox M; Danloy S; Raes K; Collen D
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):459-66. PubMed ID: 10669644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HDL2b lipoproteins as an acceptor of cholesterol from erythrocyte membrane and the role of lecithin-cholesterol-acyltransferase during this process].
    Nikiforova AA; Kheĭfets GM; Alksnis EG; Parfenova NS; Klimov AN
    Biokhimiia; 1988 Aug; 53(8):1334-8. PubMed ID: 3191196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions.
    Van Craeyveld E; Lievens J; Jacobs F; Feng Y; Snoeys J; De Geest B
    Gene Ther; 2009 Jun; 16(6):757-65. PubMed ID: 19242527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.